SOFTLENS66 TORIC (ALPHAFILCON A)VISIBILITY TINTED CONTACT LENSES

FDA Premarket Approval P960022 S003

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for a toric design with an extended wear indication from 1 to 7 days between removals for the above referenced device. The device, as modified, will be marketed under the trade name bausch & lomb soflens66 toric (alphafilcona) visibility tinted contact lenses and is indicated for extended wear from 1 to 7 days between removals, for cleaning and disinfection or disposal of the lens, as recommended by the eye care professional. The lens is indicated for the correction of refractive ametropia (myopia, hyperopia and astigmatism) in not-aphakic persons with non-diseased eyes, exhibiting astigmatism of up to 5. 00 diopters (d) that does not interfere with visual acuity. The lens may be prescribed for frequent/planned replacement wear or disposable wear in spherical powers ranging from +6. 00 d to -9. 00d when prescribed for use to 7 days of extended wear.

DeviceSOFTLENS66 TORIC (ALPHAFILCON A)VISIBILITY TINTED CONTACT LENSES
Generic NameLenses, Soft Contact, Extended Wear
ApplicantBausch & Lomb, Inc.
Date Received2003-03-03
Decision Date2003-04-04
PMAP960022
SupplementS003
Advisory CommitteeOphthalmic
Supplement TypeReal-time Process
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address Bausch & Lomb, Inc. 1400 North Goodman St. rochester, NY 14609-3547

Supplemental Filings

Supplement NumberDateSupplement Type
P960022Original Filing
S012 2020-03-20 30-day Notice
S011 2015-09-29 30-day Notice
S010 2013-10-17 30-day Notice
S009 2011-10-19 135 Review Track For 30-day Notice
S008 2011-03-03 30-day Notice
S007 2010-11-15 Normal 180 Day Track No User Fee
S006 2010-05-17 30-day Notice
S005 2008-09-24 Real-time Process
S004 2004-02-06 30-day Notice
S003 2003-03-03 Real-time Process
S002 2001-01-09 Normal 180 Day Track
S001 1997-08-07 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.